88
Views
21
CrossRef citations to date
0
Altmetric
Original Research

miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancer

, , , , , & show all
Pages 543-550 | Published online: 27 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Menha Swellam, Rasha F. K. Zahran, Hossam Abo El-Sadat Taha, Nashwa El-Khazragy & Camelia Abdel-Malak. (2019) Role of some circulating MiRNAs on breast cancer diagnosis. Archives of Physiology and Biochemistry 125:5, pages 456-464.
Read now
Fujiao Duan, Yang Yang, Weigang Liu, Jie Zhao, Xiaoqin Song, Lifeng Li & Fuqin Li. (2018) Quantifying the prognostic significance of microRNA-17/17-5P in cancers: a meta-analysis based on published studies. Cancer Management and Research 10, pages 2055-2069.
Read now

Articles from other publishers (18)

Alireza Bakhshi, Mohammad Khani, Saeed Alipour Parsa, Isa Khaheshi, Mohammad Hassan Namazi, Arash Mazouri, Peyman Bidram, Morteza Safi, Hossein Vakili, Vahid Eslami, Habib Saadat, Laleh Heidari & Nasim Sohrabifar. (2023) Investigating the expression level of miR-17-3p, miR-101-3p, miR-335-3p, and miR-296-3p in the peripheral blood of patients with acute myocardial infarction. Molecular and Cellular Biochemistry.
Crossref
Sadaf Alipour, Solmaz Khalighfard, Vahid Khori, Taghi Amiriani, Mahboubeh Tajaldini, Mohammad Dehghan, Somayeh Sadani, Ramesh Omranipour, Gelareh Vahabzadeh, Bita Eslami & Ali Mohammad Alizadeh. (2022) Innovative targets of the lncRNA-miR-mRNA network in response to low-dose aspirin in breast cancer patients. Scientific Reports 12:1.
Crossref
May Zie Koh, Wan Yong Ho, Swee Keong Yeap, Norlaily Mohd Ali, Chean Yeah Yong, Lily Boo & Noorjahan Banu Alitheen. (2022) Exosomal-microRNA transcriptome profiling of Parental and CSC-like MDA-MB-231 cells in response to cisplatin treatment. Pathology - Research and Practice 233, pages 153854.
Crossref
Xiaoqin Li, Xinyue Tang, Kunsong Li & Ling Lu. (2022) Evaluation of Serum MicroRNAs (miR-9-5p, miR-17-5p, and miR-148a-3p) as Potential Biomarkers of Breast Cancer. BioMed Research International 2022, pages 1-8.
Crossref
Peter Shaw, Greg Raymond, Raghul Senthilnathan, Chellan Kumarasamy, Siddhartha Baxi, Deepa Suresh, Sameep Shetty, Ravishankar Ram M, Harish Chandramoorthy, Palanisamy Sivanandy, Suja Samiappan, Mogana Rajagopal, Sunil Krishnan & Rama Jayaraj. (2021) Clinical Theragnostic Relationship between Chemotherapeutic Resistance, and Sensitivity and miRNA Expressions in Head and Neck Cancers: A Systematic Review and Meta-Analysis Protocol. Genes 12:12, pages 2029.
Crossref
Mengxia Zhong, Lei Che, Meiqing Du, Ke Liu & Dalong Wang. (2020) Desflurane protects against liver ischemia/reperfusion injury via regulating miR-135b-5p. Journal of the Chinese Medical Association 84:1, pages 38-45.
Crossref
Anbing Dong, Jianhua Zhang, Wenhai Sun, Hui Hua & Yinghe Sun. (2020) Upregulation of miR-421 predicts poor prognosis and promotes proliferation, migration, and invasion of papillary thyroid cancer cells. Journal of the Chinese Medical Association 83:11, pages 991-996.
Crossref
Hao Lai, Jie Zhang, Hongqun Zuo, Haizhou Liu, Jing Xu, Yan Feng, Yuan Lin & Xianwei Mo. (2020) Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer. Medicine 99:9, pages e19265.
Crossref
Andrea Ritter, Marc Hirschfeld, Kai Berner, Gerta R�cker, Markus J�ger, Daniela Weiss, Markus Medl, Claudia N�thling, Sandra Gassner, Jasmin Asberger & Thalia Erbes. (2019) Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?. International Journal of Oncology.
Crossref
Jieun Lee, Hee Eun Kim, Young-Seok Song, Eun Yoon Cho & Ahwon Lee. (2019) miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway. Breast Cancer Research and Treatment 176:1, pages 119-130.
Crossref
Rasha M. Sareyeldin, Ishita Gupta, Israa Al-Hashimi, Hamda A. Al-Thawadi, Halema F. Al Farsi, Semir Vranic & Ala-Eddin Al Moustafa. (2019) Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer. Cancers 11:5, pages 646.
Crossref
Yurong Wang, Guijuan Zhang, Xiaoqian Hao, Yi Ma, Min Ma, Xianxin Yan, Xuefeng Jiang, Fengjie Bie & Naijun Yuan. (2019) RETRACTED: Potential biomarker for breast cancer screening: A systematic review and meta-analysis. Future Generation Computer Systems 91, pages 518-526.
Crossref
Dajiang Wu, Hao Zhang, Fang Ji & Wenbin Ding. (2019) MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression. Pathology - Research and Practice 215:1, pages 115-120.
Crossref
Pavol Zubor, Peter Kubatka, Zuzana Dankova, Alexandra Gondova, Karol Kajo, Jozef Hatok, Marek Samec, Marianna Jagelkova, Stefan Krivus, Veronika Holubekova, Jan Bujnak, Zuzana Laucekova, Katarina Zelinova, Igor Stastny, Marcela Nachajova, Jan Danko & Olga Golubnitschaja. (2018) miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer. Future Oncology 14:18, pages 1847-1867.
Crossref
Xia Zhang, Yuehua Li, Dan Wang & Xiaoer Wei. (2017) miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1. Biological Research 50:1.
Crossref
Jie Li, Yuanhui Lai, Jieyi Ma, Yue Liu, Jiong Bi, Longjuan Zhang, Lianzhou Chen, Chen Yao, Weiming Lv, Guangqi Chang, Shenming Wang, Mao Ouyang & Wenjian Wang. (2017) miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer. BMC Cancer 17:1.
Crossref
Xuerong Liu, Yan Wang & Jinglong Zhao. (2017) MicroRNA-337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways. Oncology Reports 38:5, pages 3187-3196.
Crossref
Paola Mozzoni, Luca Ampollini, Matteo Goldoni, Rossella Alinovi, Marcello Tiseo, Letizia Gnetti, Paolo Carbognani, Michele Rusca, Antonio Mutti, Antonio Percesepe & Massimo Corradi. (2017) MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study. Disease Markers 2017, pages 1-10.
Crossref